Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Deferred Taxes (2016 - 2018)

Historic Deferred Taxes for China Pharma Holdings (CPHI) over the last 9 years, with Q4 2018 value amounting to -$1195.0.

  • China Pharma Holdings' Deferred Taxes fell 10391.48% to -$1195.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $68419.0, marking a year-over-year decrease of 4420.74%. This contributed to the annual value of $68419.0 for FY2018, which is 4420.74% down from last year.
  • China Pharma Holdings' Deferred Taxes amounted to -$1195.0 in Q4 2018, which was down 10391.48% from $21039.0 recorded in Q3 2018.
  • In the past 5 years, China Pharma Holdings' Deferred Taxes ranged from a high of $421825.0 in Q3 2015 and a low of -$1195.0 during Q4 2018
  • Over the past 5 years, China Pharma Holdings' median Deferred Taxes value was $21039.0 (recorded in 2018), while the average stood at $58385.9.
  • In the last 5 years, China Pharma Holdings' Deferred Taxes skyrocketed by 209529.01% in 2015 and then crashed by 10391.48% in 2018.
  • Over the past 5 years, China Pharma Holdings' Deferred Taxes (Quarter) stood at $19284.0 in 2014, then skyrocketed by 2087.44% to $421825.0 in 2015, then crashed by 42.36% to $243131.0 in 2016, then tumbled by 87.45% to $30525.0 in 2017, then plummeted by 103.91% to -$1195.0 in 2018.
  • Its Deferred Taxes stands at -$1195.0 for Q4 2018, versus $21039.0 for Q3 2018 and $22590.0 for Q2 2018.